OpenAthens has announced a partnership with ClinOwl, a new and free content discovery platform for healthcare professionals and medical researchers. There is a wealth of high quality clinical content available online. However, the content is spread across hundreds of medical journals and is often difficult and time consuming to discover.
ClinOwl is a content discovery platform that provides a solution by collating and curating the latest articles from leading medical journals into a single view. With over 30,000 articles organised into over 30 clinical specialties and sub-specialties to date, ClinOwl provides a wider view for busy healthcare professionals and researchers worldwide. To date ClinOwl has attracted users from over 170 different countries.
Content on ClinOwl is selected from the world’s leading peer-reviewed medical journals, ensuring high quality standards.
The ClinOwl COVID-19 resource hub is proving particularly popular with over 14,000 clinical research articles searchable by important keywords such as diagnosis, symptoms, guidelines and treatment.
Integration with OpenAthens single sign-on technology now allows end users to seamlessly transition from ClinOwl to access full articles on publisher sites that support institutional access.
Users who are logged in to ClinOwl via OpenAthens will also have access to additional functionality and personalisation, such as the ability to bookmark articles in their own personal folders for future reference. Researchers can also discover relevant articles based on their previous content consumption.
Researchers’ privacy is totally protected via the OpenAthens integration and no personal attributes are needed to access ClinOwl. Users have the option to sign up for free tailored email alerts if they wish.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.Click here to read the original press release.